Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older

- Seasonal Female, Maleergic Rhinitis | Hayfever
- Completed

Study Title: Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR

Teva Identifier: BDP-AR-201

ClinicalTrials.gov Identifier: NCT00854360

Study Status: Completed

Trial Condition(s): Seasonal Female, Maleergic Rhinitis | Hayfever

Interventions: Drug: Beclomethasone dipropionate HFA Nasal Aerosol | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child, Adult, Older Adult

Age Range: 12 Years and older

Trial Duration: 03/01/2009 - 05/01/2009

Phase: Phase 2

Study Type

Interventional